We are live on !
Find out more
Slocum, Gordon & Co Portfolio holdings
AUM
$143M
Turnover
11.11%
1-Year Est. Return
22.41%
This Fund
S&P 500
This Quarter Est. Return
+2.53%
1 Year Est. Return
+22.41%
3 Year Est. Return
+65.27%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$143M
AUM Growth
-$7.22M
(-4.8%)
Cap. Flow
-$7.89M
Cap. Flow % of AUM
Cap. Flow %
-5.51%
Top 10 Holdings %
Top 10 Hldgs %
52.21%
Holding
72
New
2
Increased
12
Reduced
33
Closed
6
Avg Time Held
2.4
years
Top 10 Avg Time Held
2.3
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$1.98M |
| 2 |
Dominion Energy
D
|
+$873K |
| 3 |
Weyerhaeuser
WY
|
+$223K |
| 4 |
Thermo Fisher Scientific
TMO
|
+$222K |
| 5 |
SPDR Gold Trust
GLD
|
+$107K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$3.95M |
| 2 |
Starbucks
SBUX
|
+$1.79M |
| 3 |
iShares TIPS Bond ETF
TIP
|
+$808K |
| 4 |
Sandisk
SNDK
|
+$682K |
| 5 |
Johnson & Johnson
JNJ
|
+$584K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.02% |
| 2 | Utilities | 16.86% |
| 3 | Energy | 13.63% |
| 4 | Miscellaneous | 10.41% |
| 5 | Consumer Staples | 9.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Merck
MRK
$369B
| $13.3M | 9.3% |
91,691
-1,490
| -2% | -$206K |
2022 Q4
15 quarters
|
|
|
2
Johnson & Johnson
JNJ
$658B
| $10.7M | 7.44% |
40,277
-2,212
| -5% | -$584K |
2022 Q4
15 quarters
|
|
3
ExxonMobil
XOM
$770B
| $10.5M | 7.31% |
64,376
-1,850
| -3% | -$289K |
2022 Q4
15 quarters
|
|
4
NextEra Energy
NEE
$176B
| $7.51M | 5.24% |
99,138
-2,298
| -2% | -$194K |
2025 Q1
6 quarters
|
|
5
American Electric Power
AEP
$70.9B
| $7.32M | 5.11% |
61,695
-2,105
| -3% | -$267K |
2022 Q4
15 quarters
|
|
6
Procter & Gamble
PG
$374B
| $6.72M | 4.69% |
46,266
-1,529
| -3% | -$224K |
2022 Q4
15 quarters
|
|
7
AbbVie
ABBV
$521B
| $5.26M | 3.67% |
20,100
-87
| -0.4% | -$22.3K |
2022 Q4
15 quarters
|
|
8
Verizon
VZ
$185B
| $5.17M | 3.61% |
112,786
-3,121
| -3% | -$147K |
2022 Q4
15 quarters
|
|
9
FirstEnergy
FE
$27.2B
| $4.7M | 3.28% |
108,500
+1,260
| +1% | +$59.2K |
2026 Q2
1 quarter
|
|
10
JPMorgan Chase
JPM
$895B
| $3.67M | 2.56% |
11,101
-35
| -0.3% | -$12.2K |
2022 Q4
15 quarters
|
|
|
11
iShares TIPS Bond ETF
TIP
$14.6B
| $3.62M | 2.52% |
34,772
-7,560
| -18% | -$808K |
2025 Q2
5 quarters
|
|
12
Unilever
UL
$141B
| $3.52M | 2.46% |
57,990
-191
| -0.3% | -$12K |
2022 Q4
15 quarters
|
|
13
iShares MSCI Australia ETF
EWA
$1.25B
| $3.29M | 2.3% |
116,297
-304
| -0.3% | -$8.88K |
2024 Q4
7 quarters
|
|
14
Duke Energy
DUK
$99.3B
| $3.23M | 2.25% |
28,335
+510
| +2% | +$62.5K |
2022 Q4
15 quarters
|
|
15
iShares MSCI Japan ETF
EWJ
$23.1B
| $3.04M | 2.12% |
31,234
+64
| +0.2% | +$6.09K |
2025 Q1
6 quarters
|
|
16
ConocoPhillips
COP
$185B
| $3.03M | 2.11% |
24,173
+64
| +0.3% | +$7.93K |
2025 Q3
4 quarters
|
|
17
GE Aerospace
GE
$313B
| $2.71M | 1.89% |
8,672
-537
| -6% | -$186K |
2022 Q4
15 quarters
|
|
18
Pfizer
PFE
$174B
| $2.51M | 1.75% |
88,011
-483
| -0.5% | -$12.8K |
2022 Q4
15 quarters
|
|
19
Williams Companies
WMB
$90.9B
| $2.35M | 1.64% |
34,615
-490
| -1% | -$35.6K |
2022 Q4
15 quarters
|
|
20
AT&T
T
$144B
| $2.28M | 1.59% |
93,587
-1,005
| -1% | -$24.2K |
2022 Q4
15 quarters
|
|
21
GE Vernova
GEV
$227B
| $2.16M | 1.51% |
2,273
-18
| -0.8% | -$17.8K |
2024 Q2
9 quarters
|
|
22
Apple
AAPL
$5.03T
| $1.98M | 1.38% |
5,938
-800
| -12% | -$257K |
2024 Q1
10 quarters
|
|
|
23
Starbucks
SBUX
$118B
| $1.88M | 1.31% |
20,000
-17,305
| -46% | -$1.79M |
2025 Q4
3 quarters
|
|
24
Vanguard International High Dividend Yield ETF
VYMI
$21.4B
| $1.86M | 1.3% |
18,369
-46
| -0.2% | -$4.75K |
2026 Q2
1 quarter
|
|
|
25
Zoetis
ZTS
$32.9B
| $1.85M | 1.29% |
+26,459
| New | +$1.98M |
2026 Q3
0 quarters
|
|
Similar funds
SL
FPC
Slocum, Gordon & Co's Q3 2026 Portfolio in Review
As of Q3 2026, Slocum, Gordon & Co held 72 positions worth $143M, down 4.8% from $151M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Slocum, Gordon & Co withdrew a net $7.89M in Q3 2026, closing 6 positions and reducing 33 holdings. Its most notable exit was McDonald's, an estimated $3.95M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 22% a quarter earlier, followed by Utilities and Energy.
Against the trend, Slocum, Gordon & Co opened a new position in Zoetis worth $1.85M.
- Slocum, Gordon & Co's largest Q3 2026 buy was Zoetis: 26,459 shares worth $1.85M.
- Slocum, Gordon & Co added most to Dominion Energy in Q3 2026, an estimated $873K increase.
- Slocum, Gordon & Co's biggest Q3 2026 reduction was Starbucks, cutting an estimated $1.79M.
- Slocum, Gordon & Co fully exited McDonald's in Q3 2026, selling an estimated $3.95M.
- Slocum, Gordon & Co's ten largest holdings make up 52% of its $143M portfolio in Q3 2026.
- Slocum, Gordon & Co opened 2 new positions and closed 6 in Q3 2026.
- Slocum, Gordon & Co's portfolio value fell 4.8% quarter-over-quarter to $143M.
Based on Slocum, Gordon & Co's 13F filing for Q3 2026, filed 19 Oct 2026.